Next Article in Journal
Vitamin D Status among Patients Admitted to a Geriatric Ward—Are Recommendations for Preventing Its Deficiency Effective Enough?
Next Article in Special Issue
The Portfolio Diet and HbA1c in Adults Living with Type 2 Diabetes Mellitus: A Patient-Level Pooled Analysis of Two Randomized Dietary Trials
Previous Article in Journal
The Impact of Weight Bias and Stigma on the 24 h Dietary Recall Process in Adults with Overweight and Obesity: A Pilot Study
Previous Article in Special Issue
UK Chickpea Consumption Doubled from 2008/09–2018/19
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Bean and Nut Intake Were Protective Factors for Comorbid Hypertension and Hyperuricemia in Chinese Adults: Results from China Nutrition and Health Surveillance (2015–2017)

Key Laboratory of Trace Element Nutrition of National Health Commission, National Institute for Nutrition and Health Chinese Center for Disease Control and Prevention, Beijing 100050, China
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(2), 192; https://doi.org/10.3390/nu16020192
Submission received: 21 December 2023 / Revised: 4 January 2024 / Accepted: 4 January 2024 / Published: 6 January 2024
(This article belongs to the Special Issue Consumption of Bean and Human Health)

Abstract

:
This study aimed to describe the prevalence of comorbid hypertension and hyperuricemia (HH) and detected the dietary factors for HH in Chinese adults aged 18 to 64 years. All of the data were collected from the China Nutrition and Health Surveillance 2015–2017, with a stratified, multistage, random sampling method on a national scale. A total of 52,627 adult participants aged 18~64 years from the CNHS 2015–2017 were included in this study. HH was identified as SUA level cut-offs for males and females of 420 μmol/L and 360 μmol/L, respectively, with mean systolic blood pressure ≥140 mmHg and/or mean diastolic blood pressure ≥ 90 mmHg and/or received antihypertensive treatment within two weeks. The differences in HH prevalence between or among the subgroups were compared by the Rao–Scott chi-square test. The correlations between HH and covariates or metabolic factors were detected by a weighted two-level multivariate survey logistic regression. The total weighted sufficient intake ratios of beans and nuts, vegetables, and red meat were 59.1%, 46.6%, and 64.8%, respectively. The weighted prevalence of HH in the total participants was 4.7% (95% CI: 4.3–5.0%). The positive effects of bean and nut on HH were observed. The participants who had sufficient bean and nut intake showed lower risk for HH (for the total participants: OR = 0.734, 95% CI = 0.611–0.881). The prevalence of HH might have been a public health problem, and bean and nut intake might be a protective factor for HH in the Chinese population.

1. Introduction

Uric acid (UA) is a heterocyclic compound which is the final product of purine metabolism with 168 Dalton [1]. In the human body, UA is one of the antioxidant compounds that has a function in antioxidation, for example, protecting the DNA from degradation [2]. However, the negative effects of UA have been observed in previous studies, and the organ systems could be damaged by the elevated serum uric acid (SUA) level. The potential mechanism of negative effects is considered pro-oxidant and proinflammatory [3]. Different from other animals, low solubility of UA in the human metabolic system is due to a deficiency of activated uricase [4], and that could cause UA to develop accumulatively. According to the facts, SUA is mainly excreted through the kidney; if the rate of UA generation exceeds the rate of UA elimination, UA could be accumulated and result in high SUA levels. The relativities between high SUA levels and health problems, such as gout, stroke, cancer, obesity, urate kidney stones, and even cardiovascular diseases, have all been observed in previous studies [5,6,7,8,9]. Hyperuricemia is a status of high SUA concentration. Accumulating evidence has showed that people with hyperuricemia might not only be vulnerable to developing gout but might also suffer from non-infectious chronic diseases (NCDs), even in asymptomatic conditions [10]. In recent years, the prevalent trend of hyperuricemia has attracted more and more concerns in the field of public health. In mainland China, between 2000 and 2014, the prevalence of hyperuricemia was 13.3% [11], and then, it grew to 14.6% in 2015 [12]. Similar trends have also been observed in many other countries [13,14,15]. This suggests that hyperuricemia might have gradually become a global public health problem and should be paid more attention.
As independent risk factors for cardiovascular diseases (CVDs), the effects of hyperuricemia and hypertension have been observed in previous studies. Globally, 51% of stroke (cerebrovascular disease) and 45% of ischemic heart disease deaths are attributable to high systolic blood pressure [16]. The increasing prevalence of hypertension has been considered an important risk factor for CVDs, especially in developing countries [17]. Hypertension could increase the risk of negative impacts on various target organs, and this can lead to developing stroke, coronary heart disease, or heart failure [18]. In addition, hyperuricemia could also affect the progression of hypertension [19]. Some results in previous studies showed that the risks of subclinical atherosclerosis, CVDs, renal insufficiency, and all-cause mortality could be greatly increased by the synergistic interactions between hypertension and hyperuricemia [20,21]. The results from a Kailuan Study in Tangshan, China, showed that systolic blood pressure (SBP) and diastolic blood pressure (DBP) partially mediated the effect of SUA on incident CVDs, and the mediation effect was 57.64% for SBP and 46.27% for DBP [22]. Moreover, a cross-sectional survey conducted in Xinyang, China, in 2007 among a rural population aged 40–75 showed that the prevalence of hyperuricemia in hypertensive patients was 14.1%, and the rates of gender division in males and females were 21.5% and 10.2%, respectively [23].
Among the affect factors for hypertension and hyperuricemia, the dietary factor is a key one for the disease’s prevention, retardation, or even reversal of disease progression [24]. Dietary approaches to stop hypertension (DASH), a universally acknowledged diet pattern, was initially designed for preventing or controlling hypertension. Further studies on the effects of DASH showed that it might also have some potential mechanisms of action against risk factors for metabolic syndrome [25]. Another study on Mediterranean dietary approaches to stop hypertension for neurodegenerative delay (MIND) has been regarded as a novel healthy dietary pattern with huge benefits [26]. For hyperuricemia, diet had also been declared as a determinant that could exert either positive or negative effects on hyperuricemia development [27]. It has been confirmed that the content of purine in edibles plays a key role in fluctuations in UA levels in the circulatory system [28]. A previous study conducted with Chinese elderly populations showed that dietary factor was associated with the risk of hyperuricemia [29]. These consequences above suggest that hyperuricemia combined with hypertension should be regarded with serious concerns, and the effects of special diet patterns also need to be taken seriously in target populations, even in asymptomatic groups.
This study is based on the data from the China Nutrition and Health Surveillance (CNHS) 2015–2017 and aims to detect the correlative factors, including dietary factors, for comorbid hypertension and hyperuricemia (HH) in the Chinese adult population.

2. Materials and Methods

2.1. Data Source and Samples

The cross-sectional data of the study were collected from the CNHS 2015–2017 with representation at the national level. The details of sampling that have been described in a previous study [30]. And in this study, a total of 52,627 subjects aged 18~64 years old were screened by the criteria. The screening criteria are shown as follows: (1) the family or individual information of subjects was not integrated; (2) a food frequency questionnaire (FFQ) survey was not completely conducted, or the results were out of the logical ranges; (3) outliers that existed in the laboratory test or physical examination results. Written informed consent was obtained from all subjects and their guardians.

2.2. Data Collection

Demographic characteristics and lifestyle habits of subjects were collected during a questionnaire interview conducted in a face-to-face manner, including the family and individual information. Height, weight, and blood pressure were measured by the height meter (TZG, Suzhou, China), the electronic weighing scale (G&G TC-200K, Changshu, China), and the Omron HBP-1300 electronic sphygmomanometer (Dalian, China), respectively. An FFQ was used to collect the data of dietary ingredient consumption.
The biochemical indicators, including HbA1c (glycosylated hemoglobin α-1-c), fasting blood glucose (FPG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), and SUA, were all tested by standard procedures [31].

2.3. Definition of Comorbid Hypertension and Hyperuricemia

Hyperuricemia was diagnosed according to the clinical diagnostic criteria, and the SUA level cut-off was 420 μmol/L for males and 360 μmol/L for females [32]. Hypertension was defined as mean systolic blood pressure ≥140 mmHg and/or mean diastolic blood pressure ≥ 90 mmHg and/or receiving anti-hypertension treatment within two weeks [33].

2.4. Dietary Intake Assessment

Dietary ingredients were divided into 6 kinds of food sources such as vegetable, fruit, milk, bean and nut, red meat, and alcohol. The intake of bean and nut, vegetable, fruit, and milk were assessed by the criteria of the Chinese Dietary Guidelines (2022): (1) sufficient vegetable intake was defined as a daily average intake ≥300 g; (2) sufficient fruit intake was defined as a daily average intake ≥200 g; (3) Sufficient milk intake was defined as a daily average intake ≥300 g. The quantity of milk was converted by protein content to 3.3 g/100 mL; (4) sufficient bean and nut intake was defined as a daily average intake ≥25 g; (5) the conditions of red meat intake were categorized as insufficient (daily average red meat intake < 18 g), moderate (18 g to 27 g), or excessive (>27 g) [34]; (6) alcohol consumption was categorized by international guidelines for monitoring alcohol consumption and related harm (WHO) as follows: never consumed (consume < 1 g of alcohol per day for both male and female), low-risk amount consumed (consume 1 to 40 g of alcohol per day for male or consume 1 to 20 g of alcohol per day for female), medium-risk amount consumed (consume 41 to 60 g of alcohol per day for male or consume 21 to 40 g of alcohol per day for female), or high and very high-risk amount consumed (consume ≥ 61 g of alcohol per day for male or consume ≥ 41 g of alcohol per day for female). The transfer coefficients of alcohol quantity were decided by the alcohol drink’s degree: the transfer coefficient of high-degree liquors was 50%; the transfer coefficient of low-degree liquors was 38%; the transfer coefficient of beers was 4%; the transfer coefficient of wines was 10% and the transfer coefficient of yellow rice or glutinous rice wine was 18%.

2.5. Covariates

Potential covariates were brought into the analysis: (1) gender; (2) urban and rural were categorized according to the region codes which were prescribed by the National Bureau of Statistics; (3) geographic regions were defined as east, central, and west according to the National Bureau of Statistics’ regulation, where east areas included Beijing, Tianjin, Shanghai, Hebei, Shandong, Fujian, Guangdong, Liaoning, Jiangsu, Zhejiang, and Hainan; central areas included Shanxi, Heilongjiang, Hubei, Jilin, Jiangxi, Hunan, Anhui, and Henan; west areas included Inner Mongolia, Gansu, Shaanxi, Guangxi, Guizhou, Ningxia, Chongqing, Sichuan, Yunnan, Tibet, Qinghai, and Xinjiang; (4) four age groups were established: 18–29, 30–39, 40–49, and 50–64; (5) educational situations were divided into three levels: low such as primary school or below, moderate such as junior school, and high such as high school or above; (6) four household income groups were established according to the Chinese Statistical Summary 2018: <65,141.7 CNY was identified as low, 65,141.7–193,494.9 CNY was identified as moderate, >193,494.9 CNY was identified as high, and others were unknown/unclear; (7) body mass index (BMI) was categorized as underweight, normal, overweight, and obese by the criteria of BMI < 18.5, 18.5 ≤ BMI < 24.0, 24.0 ≤ BMI < 28.0, and BMI ≥ 28.0; (8) smoking was classified as never smoked, formerly smoked, or currently smoke; (9) physical activity was categorized by the weekly total metabolic equivalent of task (MET): insufficient as MET < 600 and sufficient as MET ≥ 600 [35]; (10) the ADA 2010 criteria were used to diagnose diabetes mellitus, such as FPG level ≥ 7.0 mmol/L and/or HbA1c concentration ≥ 6.5% [36]; (11) according to the guidelines of the Chinese adult dyslipidemia prevention and treatment (2016 revised edition), dyslipidemia was identified by the criteria of total cholesterol ≥ 6.2 mmol/L, triglyceride ≥ 2.26 mmol/L, LDL ≥ 4.14 mmol/L, or HDL < 1.04 mmol/L [29]; (12) vegetarians were defined as those who consumed a plant-based diet with no eggs and dairy products.

2.6. Statistical Analysis

SAS version 9.4 software (SAS Institute Inc., Cary, NC, USA) was used for all data processing. To maintain the national representative, the weight of the sample was accessed by data from the China National Bureau Statistics. The PROC SURVEYFREQ procedure was used to calculate the demographic information of subjects. The weighted prevalence of HH was described as the case rate with a 95% confidence interval (95% CI), and the differences between or among the subgroups were compared by the Rao–Scott chi-square test. The influencing factors of HH were explored by the PROC SURVEYLOGISTIC procedure, and the results were presented as odds ratio (OR) and 95% CI by comparing them with the reference in each item. Sensitivity analysis was operated by 2 steps: The first step (model 1) was an unadjusted model. In this model, only dietary factors were included. The second step (model 2) was further adjusted for the indicators of demography, geography, and physiology. A p-value < 0.05 was considered to be statistically significant.

2.7. Quality Control

All of the staff members in this study were well trained and qualified by the China CDC project team, and all of the investigation work was conducted under strict supervision.

3. Results

3.1. Participant Characteristics

A total of 52,627 adult participants aged 18~64 years from the CNHS 2015–2017 were selected in this study, including 24,425 males and 28,202 females, and the weighted constituent ratios were 51.6% and 48.4% for males and females, respectively. The demographic and clinical characteristics of the study participants are summarized in Table 1. It shows that the weighted ratios for overweight and obesity in males (50.5%) were higher than in females (44.2%). And comparing with females, the incidences of diabetes mellitus and dyslipidemia were also observed at a higher level in males. In this study, the weighted ratios of HH were significantly higher in males (6.8%) than those in females (2.4%).

3.2. Dietary Intakes

For the dietary conditions, the total weighted sufficient intake ratios of beans and nuts, vegetables, and red meat were 59.1%, 46.6%, and 64.8%, respectively, and they were higher in males than in females. However, comparing with males, females in this study were more likely to have fruit and be vegetarian. The weighted sufficient intake ratio of fruits in females was 25.2%, even though it was at a relatively low level. And the weighted ratio of vegetarian in females was 6.2%. Significant differences in alcohol consumption between genders were observed. The weighted ratio of medium-risk and above alcohol consumption were 12.5% in males and 0.7% in females, respectively. The details are shown in Table 1.

3.3. Prevalence of HH among Participants

The weighted prevalence of HH in the total participants was 4.7% (95% CI: 4.3–5.0%). In different genders, the weighted prevalences of HH were 6.8% (95% CI: 6.2–7.5%) and 2.4% (2.1–2.6%). More details are shown in Table 2. In general, participants who were older, current smokers, heavier alcohol drinkers, consumed more red meat, and were in higher BMI groups showed a higher significant prevalence of HH. However, some discordant results were observed between the analyses in the total participants and categories of genders. For the vegetarian diet, a lower significant prevalence of HH was observed in the total participants and males but not in females. For red meat intake, significant differences were observed in total participant subgroups, but they were not observed in gender subgroups. Although no significant differences in the prevalence of bean and nut intake were detected in the total participants and male subgroup, the trends were similar to those in the female subgroup (the lower bean and nut intake subgroup had lower prevalence of HH). Meanwhile, the participants with diabetes mellitus or dyslipidemia showed a higher significant prevalence of HH in total participants and genders.

3.4. Associations between Dietary Factors and HH

Results for association between dietary factors and HH are presented in Table 3, Table 4 and Table 5 by survey logistic regression. Among the dietary correlative factors, alcohol consumption played a key role in HH. Irrespective of whether in the crude model (model 1) or in adjusted model (model 2), the negative effects of alcohol consumption on HH were observed in the total participants and genders, except for in the model 2 in females. The significant positive effects of a vegetarian diet were observed in the total participants (OR = 0.679, 95% CI = 0.462–0.996), but not in males or females. In our study, the positive effects of bean and nut intake were remarkable. It is obvious that the participants who had sufficient bean and nut intake showed lower risk for HH, even in model 2 (for the total participants, OR = 0.734, 95% CI = 0.611–0.881; for males, OR = 0.733, 95% CI = 0.587–0.917; for females, OR = 0.739, 95% CI = 0.567–0.963). Although the significant effects of red meat were not observed in all categories, similar trends also emerged.

4. Discussion

Hyperuricemia and hypertension are two NCDs that seriously threaten the cardiovascular health. Elevated SUA levels have been recognized to be associated with the risk of hypertension development [37,38]. It has been suggested that hyperuricemia combined with hypertension might cause some superimposed effects on human being health, and this needs to be paid close attention to. Meanwhile, the regulatory effects of diet on hyperuricemia and hypertension have also been confirmed. Appropriate dietary intake behaviors or adjustments in food ingredients could positively prevent or postpone the onset of NCDs, including hyperuricemia and hypertension. From the results of this study, the prevalences of hyperuricemia and hypertension are close to those in developed countries; meanwhile, the incidence of HH in the Chinese population and the positive effects of bean and nut on HH should also be paid more attention.
Due to the growing morbidity rate, hyperuricemia has gradually become an important worldwide public health issue. Elevated serum uric acid levels have been confirmed as being associated with gouty arthritis and cognized as a risk for CVDs [28,39]. In addition, the association with increased risks of onset and progression of chronic and end-stage kidney disease in hyperuricemia patients was also observed [40]. Data from the National Health and Nutrition Examination Survey (NHANES) reported that the hyperuricemia prevalence in the United States (US) was 15.9% and 14.6% in 2007–2008 and in 2015–2016, respectively. A similar result was detected in the Japan national survey; the hyperuricemia prevalence in Japan was 13.4% in 2016–2017. In our study, the overall weighted hyperuricemia prevalence was 15.1% (21.2% in males; 8.5% in females), which was consistent with the findings of Liu et al. [11], and higher than Maloberti’s results [41]. This suggested that the risk level of hyperuricemia in the Chinese population was elevated to be close to that of developed countries. This also showed that hyperuricemia appeared to be more common in males, which was consistent with NHANES’ and Zhang’s results [42]. The lower hyperuricemia prevalence in females might be attributed to the effects of estrogen [43]. In a previous study, no significant difference in hyperuricemia prevalence between genders was present in the elderly age groups with decreased hormone levels [12]. Moreover, the lifestyle of females, especially the dietary pattern, was very different from the males [29]. It had been proven in several studies that red meat and alcohol consumption were two of the riskiest factors for hyperuricemia [44,45,46], and they were obviously lower in females than in males [12].
Hypertension is one of the most important risk factors for CVD, and there is a consensus that modifying hypertension is an effective measure for improving the quality of life. However, the prevalence of hypertension in both developed and developing countries is increasing dramatically, including in the Chinese population [14,47,48]. Data from US adults in the three NHANES cycles between 2013 and 2018 showed that about 33.0% of the US adult population had hypertension [48]. The 2010–2014 Korea National Health and Nutrition Examination Survey reported that hypertension prevalence in Korean adults in males and females was 34.6% and 30.8%, respectively [49]. Another nationally representative study covering about 1,320,555 adults was conducted in India. From this study, the crude prevalence of hypertension in India was 25.3% [50]. In China, a study was conducted by Liu et al. in Chongqing in southwest China that showed that the overall hypertension prevalence among adults was 23.9%, with 23.4% in males and 24.4% in females. In our study, the total weighted prevalence of hypertension was 23.5%, (26.8% in males and 19.9% in females). The weighted prevalence of hypertension in males was significantly higher than in females. Compared with the results of these studies, our results are basically consistent with Liu’s and the Indian study’s results, whereas they are lower than the US and Korea in contemporaneity. Although the prevalence of hypertension in the Chinese population was lower than that in developed countries, it was still at a relatively high level that needs to be taken seriously, as the prevalence rate was nearly 5%, increasing compared with the data from the 2002 China National Nutrition and Health Survey (NNHS) [51].
In recent years, more attention has been paid to the negative effects of HH. A previous study found that the level of SUA was also associated with target organ damage in patients with hypertension [17]. Data from a Chinese report revealed that hyperuricemia and hypertension had accounted for more than 40% of all deaths and become the leading cause of death in China [52]. In terms of the mechanism, elevated SUA levels could induce nephropathy and vascular changes and thus lead to the development of hypertension; on the contrary, hypertension could lead to glomerular hypoxia for microvascular dysfunction and then inhibit the excretion of SUA, inducing hyperuricemia [22]. It was suggested that the temporal relationship between them might be bidirectional, and both should be given equal attention. Dietary amelioration is the cross point of the methods for preventing hyperuricemia and hypertension. In previous studies, risk factors for hyperuricemia and hypertension such as genetics, gender, age, residence location, physical inactivity, obesity, hyperlipidemia, prediabetes, and diabetes had been verified [53,54]. A reduced salt intake, moderation of alcohol intake, vegetarian diets, and fish oil supplementation were documented as having positive effects on the direction of blood pressure [24], and red meat intake, alcohol consumption, vegetarian diets, and bean and nut intake were included in the influencing factors for hyperuricemia [53]. In our study, associations between food composition and HH were detected. In the total participants, bean and nut intake, alcohol consumption, and vegetarian diets were significantly associated with HH in model 1, and the associations were not changed when further adjusted in model 2. For gender, significant associations between HH and bean and nut intake and alcohol consumption were observed in males; however, only bean and nut intake were detected as significant associations with HH in females. The rational interpretation might be the physiological characteristics and the dietary factors. For the physiological characteristics, fluctuations in estrogen concentration could be one of the causes of the differences between genders. The potential mechanisms might be the negative effects of E2 on the metabolism of SUA, and with increasing age, the prevalence of hyperuricemia between genders converged [55].
Dietary patterns, as the changeable factors, play a pivot role in the prevention of hyperuricemia and hypertension. It has been confirmed that DASH or MIND dietary patterns have positive effects on lowering blood pressure; however, some ingredients are also beneficial to hyperuricemia. In the present study, higher bean and nut intakes were found to have positive effects on lowering the risk for HH. Beans and nuts are cognized as nutritious foods. Both are rich in monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs), dietary fiber, vitamins, minerals, polyphenols, and antioxidants. PUFAs, especially ω-3 PUFAs, could improve endothelial function [56,57]. For SUA, unsaturated fatty acids, especially long-chain unsaturated fatty acids, could inhibit urate transporter 1 in the renal tubules, and then regulate the urate in the crude urine reabsorbed into the blood [58]. Moreover, some studies inferred that mineral intake was negatively correlated with hyperuricemia and hypertension [59,60]. Taking dietary magnesium (Mg), for instance, is negatively correlated with C-reactive protein levels, while the latter is positively correlated with hyperuricemia [61]. For hypertensive subjects, some studies have demonstrated that appropriate mineral supplementation, such as potassium, magnesium, or calcium, is beneficial to hypertension amelioration [62,63]. And these nutrients mentioned above are rich in the compositions of beans and nuts.
To the best of our knowledge, this study was the first to describe the prevalence of HH and detect the dietary correlative factors for HH in the Chinese population which was nationally representative. Without a doubt, alcohol consumption was still the greatest risk factor for HH due to the conclusive mechanisms. And a novel protective factor, bean and nut intake, was detected to be the common dietary protective factor for the two disorders. Simultaneously, our study had some limitations that needed to be addressed. Firstly, due to the cross-sectional design, this study cannot well elucidate the causal and temporal correlation between bean and nut intake and HH. Future prospective cohort studies and more biological experiments are needed to confirm the findings and unravel the exact mechanisms. Secondly, the diet data were collected by an FFQ to evaluate the dietary intake during the whole year, which might cause recall bias. Thirdly, due to the overall design of the CNHS (2015–2017), several covariables, such as genes, morbid state, hormone levels, emotional status, or other remaining unmeasurable factors, were not considered in this study.

5. Conclusions

The prevalence of HH should be taken seriously as it might be a public health problem, especially in the male population. The present study found that in the Chinese population, bean and nut intake might be a protective factor for HH, and the negative effects of alcohol intake on HH were verified.

Author Contributions

W.P. and D.Y. drafted the manuscript and carried out statistical analyses; L.Z. supervised the study process; X.C., Q.G., X.X., and S.L. investigated and collected information; D.Y. carried out the critical review of the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by the Chinese Nutrition Society (CNS), the Nutrition Science Foundation—Feihe Tizhi, nutrition and health research fund (CNS-Feihe2022-53), and the National Health Commission of the People’s Republic of China Medical Reform Major Program: China National Chronic Diseases and Nutrition Surveillance of Adults (2015–2017).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Chinese Center for Disease Control and Prevention (protocol code: 201519-B; date of approval: 15 June 2015).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are non-public.

Acknowledgments

We thank the investigators, the staff, and the participants from local CDCs of the CACDNS 2015 for their valuable contribution.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Li, M.; Hou, W.; Zhang, X.; Hu, L.; Tang, Z. Hyperuricemia and risk of stroke: A systematic review and meta-analysis of prospective studies. Atherosclerosis 2014, 232, 265–270. [Google Scholar] [CrossRef]
  2. Escudero-Lopez, B.; Ortega, A.; Cerrillo, I.; Rodriguez-Grinolo, M.R.; Munoz-Hernandez, R.; Macher, H.C.; Martin, F.; Hornero-Mendez, D.; Mena, P.; Del Rio, D.; et al. Consumption of orange fermented beverage improves antioxidant status and reduces peroxidation lipid and inflammatory markers in healthy humans. J. Sci. Food Agric. 2018, 98, 2777–2786. [Google Scholar] [CrossRef]
  3. Doghramji, P.P.; Wortmann, R.L. Hyperuricemia and gout: New concepts in diagnosis and management. Postgrad. Med. 2012, 124, 98–109. [Google Scholar] [CrossRef]
  4. Vogt, B. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol. Dial. Transplant. 2005, 20, 431–433. [Google Scholar] [CrossRef]
  5. Lu, X.X.; Shi, X.G.; Li, Y.B.; Chi, H.Y.; Liao, E.Y.; Liu, C.; Liu, L.B.; Li, Y.Z.; Teng, D.; Teng, X.C.; et al. A negative association between urinary iodine concentration and the prevalence of hyperuricemia and gout: A cross-sectional and population-based study in Mainland China. Eur. J. Nutr. 2020, 59, 3659–3668. [Google Scholar] [CrossRef]
  6. Sun, P.; Chen, M.Q.; Guo, X.F.; Li, Z.; Zhou, Y.; Yu, S.S.; Yang, H.M.; Sun, G.Z.; Zheng, L.Q.; Sun, Y.X. Combined effect of hypertension and hyperuricemia on ischemic stroke in a rural Chinese population. BMC Public Health 2021, 21, 776. [Google Scholar] [CrossRef]
  7. Deng, Y.; Huang, J.; Wong, M.C.S. Association between serum uric acid and prostate cancer risk in East Asian populations: A Mendelian randomization study. Eur. J. Nutr. 2022, 63, 1323–1329. [Google Scholar] [CrossRef] [PubMed]
  8. Zeng, J.; Lawrence, W.R.; Yang, J.; Tian, J.; Li, C.; Lian, W.; He, J.; Qu, H.; Wang, X.; Liu, H.; et al. Association between serum uric acid and obesity in Chinese adults: A 9-year longitudinal data analysis. BMJ Open 2021, 11, e041919. [Google Scholar] [CrossRef]
  9. Saito, Y.; Tanaka, A.; Node, K.; Kobayashi, Y. Uric acid and cardiovascular disease: A clinical review. J. Cardiol. 2021, 78, 51–57. [Google Scholar] [CrossRef] [PubMed]
  10. Cheserek, M.J.; Shi, Y.H.; Le, G.W. Association of hyperuricemia with metabolic syndrome among university workers: Sex and occupational differences. Afr. Health Sci. 2018, 18, 842–851. [Google Scholar] [CrossRef] [PubMed]
  11. Liu, R.; Han, C.; Wu, D.; Xia, X.; Gu, J.; Guan, H.; Shan, Z.; Teng, W. Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis. Biomed. Res. Int. 2015, 2015, 762820. [Google Scholar] [CrossRef] [PubMed]
  12. Piao, W.; Bo, Y.C.; Zhao, L.Y.; Yu, D.M. Status of Serum Uric Acid and Hyperuricemia among Adults in China: China Nutrition and Health Surveillance (2015). Biomed. Environ. Sci. 2022, 35, 911–920. [Google Scholar] [CrossRef] [PubMed]
  13. Zhu, Y.; Pandya, B.J.; Choi, H.K. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011, 63, 3136–3141. [Google Scholar] [CrossRef] [PubMed]
  14. Kim, S.K.; Choe, J.Y. Association between smoking and serum uric acid in Korean population Data from the seventh Korea national health and nutrition examination survey 2016. Medicine 2019, 98, e14507. [Google Scholar] [CrossRef] [PubMed]
  15. Zhang, Y.H.; Sha, M.; Zhao, Y.J.; Chen, X.Y.; Long, L.; Zhang, B.F.; Ma, H.N. Association between Serum Level of Uric Acid and Components of Metabolic Syndrome in Wanqiao Community of Dali Bai Autonomous Prefecture. J. Am. Geriatr. Soc. 2017, 65, S313. [Google Scholar]
  16. World Health Organization. Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks; World Health Organization: Geneva, Switzerland, 2009. [Google Scholar]
  17. Ofori, S.N.; Odia, O.J. Serum uric acid and target organ damage in essential hypertension. Vasc. Health Risk Manag. 2014, 10, 253–261. [Google Scholar] [CrossRef]
  18. Maloberti, A.; Rebora, P.; Occhino, G.; Alloni, M.; Musca, F.; Belli, O.; Spano, F.; Santambrogio, G.M.; Occhi, L.; De Chiara, B.; et al. Prevalence of hypertension mediated organ damage in subjects with high-normal blood pressure without known hypertension as well as cardiovascular and kidney disease. J. Hum. Hypertens. 2022, 36, 610–616. [Google Scholar] [CrossRef]
  19. Stewart, D.J.; Langlois, V.; Noone, D. Hyperuricemia and Hypertension: Links and Risks. Integr. Blood Press. Control 2019, 12, 43–62. [Google Scholar] [CrossRef]
  20. Feig, D.I. Serum uric acid and the risk of hypertension and chronic kidney disease. Curr. Opin. Rheumatol. 2014, 26, 176–185. [Google Scholar] [CrossRef]
  21. Cicero, A.F.; Salvi, P.; D’Addato, S.; Rosticci, M.; Borghi, C.; Brisighella Heart Study, g. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: Data from the Brisighella Heart Study. J. Hypertens. 2014, 32, 57–64. [Google Scholar] [CrossRef]
  22. Tian, X.; Chen, S.; Wang, P.; Xu, Q.; Zhang, Y.; Zhang, X.; Wu, S.; Luo, Y.; Wang, A. Temporal relationship between hyperuricemia and hypertension and its impact on future risk of cardiovascular disease. Eur. J. Intern. Med. 2023, 111, 82–89. [Google Scholar] [CrossRef] [PubMed]
  23. Liu, J.; Chen, L.; Yuan, H.; Huang, K.; Li, G.; Sun, N.; Huo, Y. Survey on uric acid in Chinese subjects with essential hypertension (SUCCESS): A nationwide cross-sectional study. Ann. Transl. Med. 2021, 9, 27. [Google Scholar] [CrossRef] [PubMed]
  24. Appel, L.J.; Brands, M.W.; Daniels, S.R.; Karanja, N.; Elmer, P.J.; Sacks, F.M.; American Heart, A. Dietary approaches to prevent and treat hypertension: A scientific statement from the American Heart Association. Hypertension 2006, 47, 296–308. [Google Scholar] [CrossRef] [PubMed]
  25. Akhlaghi, M. Dietary Approaches to Stop Hypertension (DASH): Potential mechanisms of action against risk factors of the metabolic syndrome. Nutr. Res. Rev. 2020, 33, 1–18. [Google Scholar] [CrossRef] [PubMed]
  26. Song, Y.; Chang, Z.; Cui, K.; Song, C.; Cai, Z.; Shi, B.; Dong, Q.; Dou, K. The value of the MIND diet in the primary and secondary prevention of hypertension: A cross-sectional and longitudinal cohort study from NHANES analysis. Front. Nutr. 2023, 10, 1129667. [Google Scholar] [CrossRef] [PubMed]
  27. Choi, H.K.; Liu, S.; Curhan, G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: The Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005, 52, 283–289. [Google Scholar] [CrossRef] [PubMed]
  28. Choi, H.K.; Atkinson, K.; Karlson, E.W.; Willett, W.; Curhan, G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 2004, 350, 1093–1103. [Google Scholar] [CrossRef] [PubMed]
  29. Yang, Y.; Piao, W.; Huang, K.; Fang, H.; Ju, L.; Zhao, L.; Yu, D.; Ma, Y. Dietary Pattern Associated with the Risk of Hyperuricemia in Chinese Elderly: Result from China Nutrition and Health Surveillance 2015–2017. Nutrients 2022, 14, 844. [Google Scholar] [CrossRef]
  30. Yu, D.; Zhao, L.; Zhang, J.; Yang, Z.; Yang, L.; Huang, J.; Fang, H.; Guo, Q.; Xu, X.; Ju, L.; et al. China Nutrition and Health Surveys (1982–2017). China CDC Wkly. 2021, 3, 193–195. [Google Scholar] [CrossRef]
  31. Pang, S.J.; Man, Q.Q.; Song, S.; Song, P.K.; Liu, Z.; Li, Y.Q.; Jia, S.S.; Wang, J.Z.; Zhao, W.H.; Zhang, J. Relationships of Insulin Action to Age, Gender, Body Mass Index, and Waist Circumference Present Diversely in Different Glycemic Statuses among Chinese Population. J. Diabetes Res. 2018, 2018, 1682959. [Google Scholar] [CrossRef]
  32. Collaborators, G.B.D.D. Health effects of dietary risks in 195 countries, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2019, 393, 1958–1972. [Google Scholar] [CrossRef]
  33. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit. Pathw. Cardiol. 2005, 4, 198–203. [Google Scholar] [CrossRef]
  34. Wei, X.Q.; Yu, D.M.; Ju, L.H.; Cheng, X.; Zhao, L.Y. Analysis of the Correlation between Eating Away from Home and BMI in Adults 18 Years and Older in China: Data from the CNNHS 2015. Nutrients 2022, 14, 146. [Google Scholar] [CrossRef] [PubMed]
  35. van der Ploeg, H.P.; Bull, F.C. Invest in physical activity to protect and promote health: The 2020 WHO guidelines on physical activity and sedentary behaviour. Int. J. Behav. Nutr. Phy. 2020, 17, 145. [Google Scholar] [CrossRef] [PubMed]
  36. Landgraf, R.; Heinemann, L.; Schleicher, E.; Gerdes, C.; Petersmann, A.; Muller-Wieland, D.; Muller, U.A.; Freckmann, G.; Thaler, M.; Ziegler, A.G.; et al. Definition, classification and diagnosis of diabetes mellitus: Update 2022. Diabetologie 2023, 19, 44–55. [Google Scholar] [CrossRef]
  37. Taniguchi, Y.; Hayashi, T.; Tsumura, K.; Endo, G.; Fujii, S.; Okada, K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J. Hypertens. 2001, 19, 1209–1215. [Google Scholar] [CrossRef] [PubMed]
  38. Han, F.; Yu, C.; Hu, F.; Zhou, W.; Wang, T.; Zhu, L.; Huang, X.; Bao, H.; Cheng, X. Association between serum uric acid levels and peripheral artery disease in Chinese adults with hypertension. Front. Endocrinol. 2023, 14, 1197628. [Google Scholar] [CrossRef] [PubMed]
  39. Zhang, C.; Jiang, L.; Xu, L.; Tian, J.; Liu, J.; Zhao, X.; Feng, X.; Wang, D.; Zhang, Y.; Sun, K.; et al. Implications of Hyperuricemia in Severe Coronary Artery Disease. Am. J. Cardiol. 2019, 123, 558–564. [Google Scholar] [CrossRef]
  40. Ponticelli, C.; Podestà, M.A.; Moroni, G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease. Kidney Int. 2020, 98, 1149–1159. [Google Scholar] [CrossRef]
  41. Maloberti, A.; Qualliu, E.; Occhi, L.; Sun, J.; Grasso, E.; Tognola, C.; Tavecchia, G.; Cartella, I.; Milani, M.; Vallerio, P.; et al. Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage. Nutr. Metab. Cardiovasc. Dis. 2021, 31, 178–185. [Google Scholar] [CrossRef]
  42. Zhang, M.; Zhu, X.X.; Wu, J.; Huang, Z.J.; Zhao, Z.P.; Zhang, X.; Xue, Y.; Wan, W.G.; Li, C.; Zhang, W.R.; et al. Prevalence of Hyperuricemia among Chinese Adults: Findings from Two Nationally Representative Cross-Sectional Surveys in 2015-16 and 2018-19. Front. Immunol. 2022, 12, 791983. [Google Scholar] [CrossRef] [PubMed]
  43. Guan, S.C.; Tang, Z.; Fang, X.H.; Wu, X.G.; Liu, H.J.; Wang, C.X.; Hou, C.B. Prevalence of hyperuricemia among Beijing post-menopausal women in 10 years. Arch. Gerontol. Geriat. 2016, 64, 162–166. [Google Scholar] [CrossRef]
  44. Kakutani-Hatayama, M.; Kadoya, M.; Okazaki, H.; Kurajoh, M.; Shoji, T.; Koyama, H.; Tsutsumi, Z.; Moriwaki, Y.; Namba, M.; Yamamoto, T. Nonpharmacological Management of Gout and Hyperuricemia: Hints for Better Lifestyle. Am. J. Lifestyle Med. 2017, 11, 321–329. [Google Scholar] [CrossRef]
  45. Li, R.; Yu, K.; Li, C. Dietary factors and risk of gout and hyperuricemia: A meta-analysis and systematic review. Asia Pac. J. Clin. Nutr. 2018, 27, 1344–1356. [Google Scholar] [CrossRef]
  46. Makinouchi, T.; Sakata, K.; Oishi, M.; Tanaka, K.; Nogawa, K.; Watanabe, M.; Suwazono, Y. Benchmark dose of alcohol consumption for development of hyperuricemia in Japanese male workers: An 8-year cohort study. Alcohol 2016, 56, 9–14. [Google Scholar] [CrossRef]
  47. Liu, X.; Gu, W.; Li, Z.; Lei, H.; Li, G.; Huang, W. Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: An update. J. Hypertens. 2017, 35, 637–644. [Google Scholar] [CrossRef]
  48. Aggarwal, R.; Chiu, N.; Wadhera, R.K.; Moran, A.E.; Raber, I.; Shen, C.; Yeh, R.W.; Kazi, D.S. Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018. Hypertension 2021, 78, 1719–1726. [Google Scholar] [CrossRef]
  49. Choi, H.M.; Kim, H.C.; Kang, D.R. Sex differences in hypertension prevalence and control: Analysis of the 2010–2014 Korea National Health and Nutrition Examination Survey. PLoS ONE 2017, 12, e0178334. [Google Scholar] [CrossRef]
  50. Geldsetzer, P.; Manne-Goehler, J.; Theilmann, M.; Davies, J.I.; Awasthi, A.; Vollmer, S.; Jaacks, L.M.; Barnighausen, T.; Atun, R. Diabetes and Hypertension in India: A Nationally Representative Study of 1.3 Million Adults. JAMA Intern. Med. 2018, 178, 363–372. [Google Scholar] [CrossRef]
  51. Wu, Y.; Huxley, R.; Li, L.; Anna, V.; Xie, G.; Yao, C.; Woodward, M.; Li, X.; Chalmers, J.; Gao, R.; et al. Prevalence, awareness, treatment, and control of hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation 2008, 118, 2679–2686. [Google Scholar] [CrossRef]
  52. Chen, W.W.; Gao, R.L.; Liu, L.S.; Zhu, M.L.; Wang, W.; Wang, Y.J.; Wu, Z.S.; Li, H.J.; Gu, D.F.; Yang, Y.J.; et al. China cardiovascular diseases report 2015: A summary. J. Geriatr. Cardiol. 2017, 14, 1–10. [Google Scholar] [CrossRef] [PubMed]
  53. Piao, W.; Zhao, L.Y.; Yang, Y.X.; Fang, H.Y.; Ju, L.H.; Cai, S.Y.; Yu, D.M. The Prevalence of Hyperuricemia and Its Correlates among Adults in China: Results from CNHS 2015–2017. Nutrients 2022, 14, 4095. [Google Scholar] [CrossRef] [PubMed]
  54. Shen, Y.; Chang, C.; Zhang, J.R.; Jiang, Y.; Ni, B.Y.; Wang, Y.L. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: A cross-sectional study. Environ. Health Prev. 2017, 22, 19. [Google Scholar] [CrossRef] [PubMed]
  55. Huang, X.B.; Zhang, W.Q.; Tang, W.W.; Liu, Y.; Ning, Y.; Huang, C.; Liu, J.X.; Yi, Y.J.; Xu, R.H.; Wang, T.D. Prevalence and associated factors of hyperuricemia among urban adults aged 35–79 years in southwestern China: A community-based cross-sectional study. Sci. Rep. 2020, 10, 15683. [Google Scholar] [CrossRef] [PubMed]
  56. Miyoshi, T.; Noda, Y.; Ohno, Y.; Sugiyama, H.; Oe, H.; Nakamura, K.; Kohno, K.; Ito, H. Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals—A randomized cross-over trial. Biomed. Pharmacother. 2014, 68, 1071–1077. [Google Scholar] [CrossRef] [PubMed]
  57. Tousoulis, D.; Plastiras, A.; Siasos, G.; Oikonomou, E.; Verveniotis, A.; Kokkou, E.; Maniatis, K.; Gouliopoulos, N.; Miliou, A.; Paraskevopoulos, T.; et al. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis 2014, 232, 10–16. [Google Scholar] [CrossRef]
  58. Saito, H.; Toyoda, Y.; Takada, T.; Hirata, H.; Ota-Kontani, A.; Miyata, H.; Kobayashi, N.; Tsuchiya, Y.; Suzuki, H. Omega-3 Polyunsaturated Fatty Acids Inhibit the Function of Human URAT1, a Renal Urate Re-absorber. Nutrients 2020, 12, 1601. [Google Scholar] [CrossRef]
  59. Machado, A.D.; Andrade, G.R.G.; Levy, J.; Ferreira, S.S.; Marchioni, D.M. Association between Vitamins and Minerals with Antioxidant Effects and Coronary Artery Calcification in Adults and Older Adults: A Systematic Review. Curr. Pharm. Des. 2019, 25, 2474–2479. [Google Scholar] [CrossRef]
  60. Li, L.Z.; Zhou, G.X.; Li, J.; Jiang, W.; Liu, B.L.; Zhou, W. Compounds containing trace element copper or zinc exhibit as potent hyperuricemia inhibitors via xanthine oxidase inactivation. J. Trace Elem. Med. Bio. 2018, 49, 72–78. [Google Scholar] [CrossRef]
  61. Zhang, Y.Y.; Qiu, H.B. Dietary Magnesium Intake and Hyperuricemia among US Adults. Nutrients 2018, 10, 296. [Google Scholar] [CrossRef]
  62. Jones, D.W.; Clark, D.; Morgan, T.O.; He, F.J. Potassium-Enriched Salt Substitution as a Population Strategy to Prevent Cardiovascular Disease. Hypertension 2022, 79, 2199–2201. [Google Scholar] [CrossRef] [PubMed]
  63. Kisters, K.; Groeber, U.; Kisters, L. Increased Ionized Calcium-Magnesium Ratio in Elderly Hypertensives. J. Hypertens. 2023, 41, E98–E99. [Google Scholar] [CrossRef]
Table 1. Demographic, dietary, and clinical characteristics of all participants in this study.
Table 1. Demographic, dietary, and clinical characteristics of all participants in this study.
Overall Male Female%p-Value *
N% N % N
Total52,62710024,42551.628,20248.4
Bean and nut intake
Insufficient23,91940.910,61439.113,30542.9<0.0001
Sufficient28,70859.113,81160.914,89757.1
Vegetable intake
Insufficient28,55953.412,91451.715,64555.2<0.0001
Sufficient24,06846.611,51148.312,55744.8
Fruit intake
Insufficient42,64278.420,44181.722,20174.8<0.0001
Sufficient998521.6398418.3600125.2
Milk intake
Insufficient51,65798.024,05339.127,60442.90.0878
Sufficient9702.037260.959857.1
Red meat intake
Insufficient15,02626.5550320.0952333.5<0.0001
Moderate44638.718057.3265810.2
Excessive33,13864.817,11772.716,02156.4
Alcohol consumption
Never37,81069.411,88347.925,92792.3<0.0001
Low risk10,71223.9874639.719667.0
Medium risk15132.613464.61670.4
High and very high risk25924.224507.91420.3
Vegetarian
No49,76094.923,36695.926,39493.8<0.0001
Yes28675.110594.118086.2
Residence location
Urban21,14352.3957653.511,56751.20.0110
Rural31,48447.714,84946.516,63548.8
Geographic region
East20,61244.5949545.111,11743.80.3167
Central14,86830.3688929.8797930.9
West17,14725.2804125.1910625.3
Age group (years)
18~29564226.6249326.4314926.70.6759
30~39779623.3353423.6426222.9
40~4914,39925.7659525.4780426.1
50~6424,79024.511,80324.612,98724.3
Education level
Low22,31629.0824722.514,06936.1<0.0001
Moderate17,98435.3965838.4832632.0
High12,32735.7652039.1580732.0
Household income
Low34,91760.416,32460.418,59360.50.0544
Moderate849020.8391421.3457620.2
High9292.54302.74992.3
Unknown829116.3375715.6453417.1
BMI
Wasting20675.18564.712115.6<0.0001
Normal24,29447.411,13344.813,16150.2
Overweight18,54833.1890735.4964130.7
Obese771814.3352915.1418913.5
Smoking
Never35,71767.3832738.427,39097.9<0.0001
Former14,14228.413,47153.46711.7
Current27684.426278.11410.4
Physical activity
Insufficient29,96264.012,98460.916,97867.2<0.0001
Sufficient22,66536.011,44139.111,22432.8
Diabetes mellitus
No48,48794.022,38193.626,10694.50.0076
Yes41406.020446.420965.5
Dyslipidemia
No31,72461.713,19753.918,52770.1<0.0001
Yes20,90338.311,22846.1967529.9
Hyperuricemia
No45,63384.919,95878.825,67591.5<0.0001
Yes699415.1446721.225278.5
Hypertension
No35,74376.515,91773.219,82680.1<0.0001
Yes16,88423.5850826.8837619.9
Hypertension and Hyperuricemia
No49,73995.322,54693.227,19397.6<0.0001
Yes28884.718796.810092.4
* p-value indicates statistical significance of the differences between genders. Constituent ratios are weighted. The values of polytomous variables may not sum to 100% due to rounding. Abbreviation: BMI—body mass index.
Table 2. Weighted prevalence of HH among participants.
Table 2. Weighted prevalence of HH among participants.
TotalMalesFemales
%95% CIp-Value *%95% CIp-Value *%95% CIp-Value *
Total4.7 (4.3–5.0) 6.8(6.2–7.5) 2.4 (2.1–2.6)
Residence location
Urban4.9 (4.4–5.5)0.1151 7.2(6.2–8.2)0.17712.4 (2.0–2.8)0.7726
Rural4.4 (3.9–4.8) 6.4(5.6–7.1) 2.3 (2.0–2.7)
Area of the country
East5.1 (4.5–5.8)0.0627 7.4(6.4–8.4)0.22552.7 (2.2–3.1)0.1362
Central4.4 (3.7–5.0) 6.6(5.4–7.7) 2.1 (1.7–2.6)
West4.2 (3.6–4.8) 6.1(5.1–7.1) 2.2 (1.7–2.6)
Age (years)
18~292.5 (1.7–3.3)<0.00014.1(2.8–5.5)<0.00010.8 (0.1–1.6)<0.0001
30~393.6 (2.9–4.2) 5.9(4.6–7.1) 1.0 (0.6–1.5)
40~495.3 (4.6–6.1) 8.2(7.0–9.4) 2.4 (1.9–2.9)
50~647.3 (6.7–7.9) 9.2(8.3–10.1) 5.3 (4.6–5.9)
Education level
Low5.0 (4.4–5.7)0.2220 7.5(6.2–8.7)0.47523.4 (2.9–3.9)<0.0001
Moderate4.8 (4.3–5.4) 6.9(6.0–7.8) 2.2 (1.7–2.7)
High4.2 (3.4–5.0) 6.4(5.1–7.6) 1.4 (0.8–2.0)
Household income
Low4.8 (4.3–5.2)0.4067 6.9(6.2–7.7)0.22772.5 (2.2–2.8)0.4267
Moderate4.8 (3.9–5.7) 7.5(5.9–9.1) 1.9 (1.4–2.3)
High3.3 (1.8–4.9) 4.4(1.8–7.0) 2.0 (0.7–3.3)
Unknown4.1 (3.1–5.2) 5.8(4.5–7.2) 2.5 (1.4–3.6)
BMI
Wasting1.5 (0.1–3.0)<0.00010.9(0.1–1.6)<0.00012.1 (0.0–4.7)<0.0001
Normal1.7 (1.4–1.9) 2.6(2.1–3.0) 0.8 (0.6–1.0)
Overweight6.2 (5.4–6.9) 8.8(7.6–10.0) 2.9 (2.4–3.4)
Obese12.2 (10.7–13.8) 16.6(14.1–19.1) 7.1 (5.8–8.4)
Smoking
Never3.7 (3.3–4.1)<0.00016.9(5.8–7.9)0.00092.4 (2.1–2.6)0.6889
Former6.1 (5.3–6.9) 6.2(5.4–7.0) 2.8 (1.1–4.6)
Current10.4 (7.9–12.9) 10.7(8.2–13.3) 3.7 (0.0–8.6)
Physically active
Insufficient4.7 (4.3–5.2)0.5658 7.3(6.4–8.2)0.03232.2 (1.9–2.6)0.2563
Sufficient4.5 (4.0–5.1) 6.0(5.2–6.9) 2.6 (2.1–3.1)
Diabetes mellitus
No4.3 (4.0–4.7)<0.00016.5(5.9–7.1)<0.00012.1 (1.8–2.3)<0.0001
Yes9.7 (8.1–11.4) 11.7(9.2–14.2) 7.3 (5.6–9.0)
Dyslipidemia
No2.3 (2.0–2.6)<0.00013.6(3.0–4.2)<0.00011.3 (1.0–1.5)<0.0001
Yes8.5 (7.7–9.2) 10.6(9.5–11.7) 4.9 (4.2–5.7)
Bean and nut intake
Insufficient5.0 (4.4–5.6)0.1143 7.3(6.2–8.4)0.23552.8 (2.3–3.2)0.0106
Sufficient4.4 (4.0–4.9) 6.5(5.7–7.3) 2.1 (1.8–2.4)
Vegetable intake
Insufficient4.3 (3.8–4.8)0.0231 6.4(5.5–7.3)0.20352.1 (1.7–2.5)0.0965
Sufficient5.1 (4.6–5.6) 7.2(6.4–8.1) 2.6 (2.2–3.0)
Fruit intake
Insufficient4.7 (4.3–5.1)0.7301 6.8(6.1–7.4)0.67882.3 (2.0–2.6)0.6510
Sufficient4.5 (3.6–5.4) 7.1(5.5–8.8) 2.5 (1.7–3.3)
Milk intake
Insufficient4.7 (4.3–5.1)0.2027 6.9(6.2–7.5)0.2072.4 (2.1–2.6)0.8373
Sufficient3.4 (1.6–5.1) 4.3(1.2–7.5) 2.6 (0.6–4.6)
Red meat intake
Insufficient3.9 (3.4–4.4)0.0007 5.9(4.8–7.1)0.13722.6 (2.1–3.1)0.3871
Moderate3.6 (2.7–4.6) 5.9(4.0–7.8) 1.9 (1.1–2.7)
Excessive5.1 (4.6–5.6) 7.2(6.4–7.9) 2.3 (1.9–2.7)
Alcohol consumption
Never3.5 (3.2–3.8)<0.00015.5(4.7–6.2)<0.00012.4 (2.1–2.7)0.0907
Low risk6.1 (5.1–7.0) 6.8(5.7–7.9) 1.7 (1.0–2.3)
Medium risk9.7 (6.8–12.7) 10.4(7.2–13.5) 1.9 (0.2–3.7)
High and very high risk12.7 (10.6–14.8) 13.0(10.8–15.2) 4.0 (0.8–7.2)
Vegetarian
No4.8 (4.4–5.2)0.0050 6.9(6.3–7.6)0.03882.4 (2.1–2.7)0.2862
Yes2.9 1.9–3.9 4.42.5–6.3 1.8 0.9–2.7
* p-value indicates statistical significance of the differences among subgroups for each factor. Abbreviation: HH—comorbid hypertension and hyperuricemia; BMI—body mass index; 95% CI—95% confidence interval.
Table 3. Association between dietary factors and HH in the total participants.
Table 3. Association between dietary factors and HH in the total participants.
Model 1Model 2
OR(95% CI)Fp-ValueOR(95% CI)Fp-Value
Bean and nut intake
InsufficientRef. 8.970.0029Ref. 11.000.0010
Sufficient0.767(0.645–0.913) 0.734(0.611–0.881)
Vegetable intake
InsufficientRef. 3.540.0604Ref. 2.520.1133
Sufficient1.176(0.993–1.392) 1.147(0.968–1.361)
Fruit intake
InsufficientRef. 0.020.8828Ref. 0.040.8463
Sufficient1.019(0.792–1.311) 1.025(0.796–1.322)
Milk intake
InsufficientRef. 0.880.3474Ref. 0.440.5089
Sufficient0.77(0.447–1.328) 0.818(0.450–1.487)
Red meat intake
InsufficientRef. 2.090.1249Ref. 1.860.1565
Moderate0.865(0.627–1.195) 0.889(0.639–1.237)
Excessive1.119(0.934–1.34) 1.135(0.943–1.368)
Alcohol consumption
NeverRef. 72.07<0.0001Ref. 19.37<0.0001
Low risk1.802(1.502–2.161) 1.293(1.045–1.600)
Medium risk2.972(2.083–4.242) 1.678(1.118–2.520)
High and very high risk4.014(3.285–4.905) 2.544(1.997–3.240)
Vegetarian
NoRef. 3.940.0478Ref. 4.090.0436
Yes0.679(0.462–0.996) 0.659(0.439–0.988)
Model 1 was an unadjusted model; model 2 was further adjusted for gender, residence location, area of the country, age, education level, household income, body mass index (BMI), smoking, physical active, diabetes mellitus, and dyslipidemia. Abbreviation: OR—odds ratio; 95% CI—95% confidence interval; F—value of F test.
Table 4. Association between dietary factors and HH in males.
Table 4. Association between dietary factors and HH in males.
Model 1Model 2
OR(95% CI)Fp-ValueOR(95% CI)Fp-Value
Bean and nut intake
InsufficientRef. 4.400.0365Ref. 7.460.0065
Sufficient0.795(0.642–0.986) 0.733(0.587–0.917)
Vegetable intake
InsufficientRef. 1.230.2676Ref. 1.580.2090
Sufficient1.119(0.917–1.365) 1.138(0.930–1.393)
Fruit intake
InsufficientRef. 0.320.5723Ref. 0.120.7302
Sufficient1.087(0.813–1.453) 0.949(0.706–1.276)
Milk intake
InsufficientRef. 1.080.2989Ref. 1.240.2665
Sufficient0.668(0.311–1.433) 0.637(0.287–1.413)
Red meat intake
InsufficientRef. 0.790.4536Ref. 1.480.2293
Moderate0.935(0.637–1.372) 0.925(0.624–1.372)
Excessive1.115(0.888–1.400) 1.182(0.930–1.501)
Alcohol consumption
NeverRef. 26.99<0.0001Ref. 20.20<0.0001
Low risk1.289(1.029–1.614) 1.350(1.071–1.701)
Medium risk2.028(1.413–2.909) 1.793(1.177–2.732)
High and very high risk2.635(2.110–3.291) 2.692(2.095–3.459)
Vegetarian
NoRef. 2.600.1078Ref. 3.010.0835
Yes0.677(0.421–1.089) 0.640(0.386–1.061)
Model 1 was an unadjusted model; model 2 was further adjusted for gender, residence location, area of the country, age, education level, household income, body mass index (BMI), smoking, physical active, diabetes mellitus, and dyslipidemia. Abbreviation: OR—odds ratio; 95% CI—95% confidence interval; F—value of F test.
Table 5. Association between dietary factors and HH in females.
Table 5. Association between dietary factors and HH in females.
Model 1Model 2
OR(95% CI)Fp-ValueOR(95% CI)Fp-Value
Bean and nut intake
InsufficientRef. 7.460.0065Ref. 5.040.0252
Sufficient0.733(0.587–0.917) 0.739(0.567–0.963)
Vegetable intake
InsufficientRef. 1.580.2090Ref. 1.300.2547
Sufficient1.138(0.930–1.393) 1.171(0.892–1.537)
Fruit intake
InsufficientRef. 0.120.7302Ref. 1.420.2345
Sufficient0.949(0.706–1.276) 1.295(0.845–1.986)
Milk intake
InsufficientRef. 0.2665Ref. 0.350.5567
Sufficient0.637(0.287–1.413)1.24 1.272(0.569–2.843)
Red meat intake
InsufficientRef. 1.480.2293Ref. 0.380.6833
Moderate0.925(0.624–1.372) 0.830(0.504–1.366)
Excessive1.182(0.930–1.501) 1.034(0.752–1.423)
Alcohol consumption
NeverRef. 20.20<0.0001Ref. 0.680.5661
Low risk1.350(1.071–1.701) 0.781(0.487–1.254)
Medium risk1.793(1.177–2.732) 0.624(0.22–1.772)
High and very high risk2.692(2.095–3.459) 1.144(0.351–3.724)
Vegetarian
NoRef. 3.010.0835Ref. 1.540.2145
Yes0.717(0.406–1.266) 0.693(0.388–1.237)
Model 1 was an unadjusted model; model 2 was further adjusted for gender, residence location, area of the country, age, education level, household income, body mass index (BMI), smoking, physical active, diabetes mellitus, and dyslipidemia. Abbreviation: OR—odds ratio; 95% CI—95% confidence interval; F—value of F test.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Piao, W.; Li, S.; Guo, Q.; Cheng, X.; Xu, X.; Zhao, L.; Yu, D. Bean and Nut Intake Were Protective Factors for Comorbid Hypertension and Hyperuricemia in Chinese Adults: Results from China Nutrition and Health Surveillance (2015–2017). Nutrients 2024, 16, 192. https://doi.org/10.3390/nu16020192

AMA Style

Piao W, Li S, Guo Q, Cheng X, Xu X, Zhao L, Yu D. Bean and Nut Intake Were Protective Factors for Comorbid Hypertension and Hyperuricemia in Chinese Adults: Results from China Nutrition and Health Surveillance (2015–2017). Nutrients. 2024; 16(2):192. https://doi.org/10.3390/nu16020192

Chicago/Turabian Style

Piao, Wei, Shujuan Li, Qiya Guo, Xue Cheng, Xiaoli Xu, Liyun Zhao, and Dongmei Yu. 2024. "Bean and Nut Intake Were Protective Factors for Comorbid Hypertension and Hyperuricemia in Chinese Adults: Results from China Nutrition and Health Surveillance (2015–2017)" Nutrients 16, no. 2: 192. https://doi.org/10.3390/nu16020192

APA Style

Piao, W., Li, S., Guo, Q., Cheng, X., Xu, X., Zhao, L., & Yu, D. (2024). Bean and Nut Intake Were Protective Factors for Comorbid Hypertension and Hyperuricemia in Chinese Adults: Results from China Nutrition and Health Surveillance (2015–2017). Nutrients, 16(2), 192. https://doi.org/10.3390/nu16020192

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop